What Is Breast Density Category B on a Mammogram?

Breast density category B, labeled “scattered areas of fibroglandular density” under the standardized system radiologists use, means your breast tissue is mostly fatty with some patches of denser fibroglandular tissue mixed in. It falls on the lower end of a four-tier scale and is grouped alongside category A as “nondense,” which carries practical implications for both cancer risk and how reliably a mammogram can detect problems. Most women who receive this result can feel reassured that standard mammographic screening works well for their breast type, though the classification is more nuanced than a single letter might suggest.

The Four-Category System

Radiologists classify breast density using the Breast Imaging Reporting and Data System, commonly called BI-RADS, developed by the American College of Radiology. The system sorts breast tissue into four groups based on the proportion of fibroglandular tissue relative to fatty tissue: category A (almost entirely fatty), category B (scattered fibroglandular density), category C (heterogeneously dense), and category D (extremely dense).¹ Categories A and B are collectively referred to as “nondense” or “low-density,” while C and D are considered “dense” or “high-density.”

On a mammogram, fatty tissue appears dark and translucent, while fibroglandular tissue shows up as white or light gray. If you have category B breasts, the image will be predominantly dark with scattered lighter patches. The distinction matters because cancers also appear white on a mammogram, so the more white fibroglandular tissue present, the harder it can be to spot a tumor hiding behind it. With category B, there is enough fatty background that cancers tend to stand out relatively well against the surrounding tissue.

What Category B Means for Cancer Risk

One of the first questions people ask after learning their density category is whether it affects their chance of developing breast cancer. The short answer for category B is that it sits in the lower-risk tier. Research consistently groups categories A and B together as “nondense” when comparing cancer risk against “dense” breasts (categories C and D). A large epidemiological study estimated that women with dense breasts had roughly 1.7 to 1.8 times the risk of being diagnosed with breast cancer compared to women with nondense breasts.² That comparison puts category B on the favorable side of the divide.

That said, category B is not category A. Having scattered fibroglandular density means you carry slightly more glandular tissue than someone whose breasts are almost entirely fatty. The relationship between fibroglandular tissue and cancer risk exists on a continuum rather than flipping like a switch at the border between B and C. Still, the jump in risk is most meaningful between nondense and dense categories. If your mammogram report says category B, you are not in the elevated-risk group that dense-breast screening laws and supplemental imaging guidelines are primarily designed to address.

How Well Standard Mammograms Perform for Category B

Mammographic sensitivity, meaning the ability of the exam to catch a cancer that is actually there, varies with breast density. For nondense breasts (categories A and B), sensitivity has been estimated at around 88%, compared to roughly 78% for dense breasts.² That ten-percentage-point gap is sometimes called the “masking effect” because dense tissue can mask or hide tumors on the image. With category B, the masking effect is relatively modest. Standard two-dimensional mammography works well for most women in this group.

This is one of the reasons that supplemental screening with MRI or ultrasound is not routinely recommended for category B. Those additional tools are aimed primarily at women with heterogeneously or extremely dense tissue, where the masking effect is much more pronounced. A large study on supplemental imaging use found that women who consistently had dense breasts were nearly four times as likely to receive a breast MRI compared to women who never had dense breasts.³ Category B patients, falling into the nondense group, typically continue with standard mammographic screening at recommended intervals unless other individual risk factors (such as a strong family history or a known genetic mutation) indicate otherwise.

3D Mammography and Dense Versus Nondense Breasts

Digital breast tomosynthesis, often marketed as “3D mammography,” takes multiple low-dose X-ray images of the breast from different angles and reconstructs them into thin slices. This technology has shown benefits across all density levels, but the gains are most dramatic for women with the densest tissue. In a European screening trial, the densest breast group saw sensitivity jump from about 43% with standard digital mammography to roughly 81% with tomosynthesis.⁴ For women at the lower end of the density spectrum, standard mammography already performs well, so the incremental improvement from tomosynthesis is smaller.

The randomized TOSYMA trial similarly found that the cancer-detection advantage of tomosynthesis plus synthesized mammography over standard digital mammography varied with breast density, with denser breasts benefiting more.⁵ If you have category B breasts and your screening center uses tomosynthesis, you are still likely getting some marginal benefit. But the technology is not solving the same urgent problem for you that it solves for someone in category D, where standard mammography misses more than half of cancers.

Can Your Density Category Change?

Breast density is not fixed for life. The single biggest factor driving density downward is age. As women move through menopause, fibroglandular tissue tends to be replaced by fatty tissue, and many women shift from a higher category to a lower one over the years. A woman classified as category C in her forties might find herself reclassified as category B in her fifties or sixties. The reverse trajectory, going from B to C, is less common but does happen in certain circumstances.

Hormone therapy is one factor that can push density in the opposite direction. Research on postmenopausal hormone therapy and breast density has produced mixed findings. Some studies report no effect on density, while others find that continuous combined hormonal therapy increases it.⁶ If you are on hormone replacement therapy and your mammogram report shows a shift from B to C, that hormonal influence could be a contributing factor. Other variables, including body weight (higher body fat tends to lower mammographic density) and certain medications like tamoxifen (which can reduce density), also play a role. The practical takeaway is that a single mammogram gives you a snapshot, not a permanent label. Your density category at age 50 may differ from your category at 60.

Why Two Radiologists Might Read the Same Mammogram Differently

One underappreciated reality about breast density classification is that it involves a judgment call. A radiologist looks at your mammogram and estimates how much of the breast appears fibroglandular versus fatty, then assigns one of the four categories. Different radiologists can look at the same image and land on different letters, particularly for breasts that sit near the boundary between two categories. Research has found that agreement among radiologists on BI-RADS density is only moderate, with statistical measures of agreement (called kappa values) hovering around 0.48 to 0.57.⁷ ⁸

This means if you switch screening centers or your images are read by a different radiologist, you might see your classification change from B to C or from B to A, even if your actual breast tissue has not changed at all. The boundary between B and C is especially consequential because it is the line many state laws and screening guidelines use to determine whether you should be notified about dense breasts or offered supplemental screening. Automated volumetric software, which measures the actual volume of dense tissue in the breast using a computer algorithm, has been developed partly to reduce this variability. These tools show a strong correlation with human assessments overall but do not always agree on borderline cases either.

If you received a category B result one year and a category C the next without any obvious reason for the change, it is worth asking your provider whether the shift might reflect reader variability rather than a genuine change in your tissue. Some clinics now include both the radiologist’s visual assessment and an automated density measurement in reports, giving you a more complete picture.

Dense-Breast Notification Laws and Where Category B Fits

Across the United States, federal law now requires mammography facilities to notify patients about their breast density. Similar policies exist or are being adopted in other countries, including Australia, where breast density notification has been introduced into organized screening programs.⁹ The specific language in your notification letter depends on where you live and which category you fall into.

For category B, the notification will typically tell you that your breasts have scattered areas of dense tissue. In most jurisdictions, the letter does not trigger a recommendation for supplemental screening the way a category C or D result would. But the fact that a density letter arrives at all can cause confusion. Some women receive the notification and assume any mention of “dense tissue” is a warning sign. In reality, category B is considered nondense, and the notification is largely informational. The laws are primarily designed to alert women with heterogeneously or extremely dense tissue to the limitations of standard mammography and to prompt conversations about whether additional imaging might help.

Studies examining how women react to density notifications have been somewhat reassuring. One study measuring anxiety levels in women notified of their breast density found no significant difference in anxiety between women told they had dense breasts and those told they had nondense breasts.¹⁰ The majority of reactions to density notification were positive or neutral, with about 17% being negative. That said, the notification letters themselves can be confusing, sometimes written in clinical language that does not clearly explain what each category means. If your letter mentions “scattered fibroglandular densities” without much context, it is easy to read that as something alarming when it is actually among the more favorable findings.

When Category B Still Warrants Extra Attention

Being classified as category B does not mean you can skip mammograms or ignore other risk factors. Breast density is one piece of a larger puzzle. A woman with category B density but a first-degree relative who had breast cancer, a known BRCA mutation, or a history of chest radiation before age 30 may still qualify for enhanced screening, including annual breast MRI. Risk-assessment tools used by clinicians incorporate density alongside family history, age, reproductive history, and other variables to estimate a woman’s overall lifetime risk. The density category alone does not determine your screening plan.

There are also situations where category B breasts can still obscure findings. Scattered areas of fibroglandular tissue are, by definition, not distributed evenly. If a cancer happens to develop directly behind one of those scattered patches of dense tissue, it can be harder to see, even though the overall density level is low. Radiologists are trained to look carefully at these areas, but no screening method catches every cancer. The estimated 88% sensitivity for nondense breasts means roughly one in eight cancers in this group is still missed on mammography. That number is better than the miss rate for dense breasts, but it is a reminder that screening is not perfect for anyone.

Lifestyle Factors and Breast Density

Researchers have explored whether changes in diet, exercise, alcohol intake, or body weight can shift breast density. The evidence is mixed and often modest. Higher body mass index is consistently linked to lower mammographic density, largely because more body fat increases the proportion of fatty tissue in the breast. But that does not mean gaining weight is a strategy for reducing density: higher body weight is itself associated with increased breast cancer risk after menopause, so any theoretical benefit from lower density would be offset by other risk pathways.¹

Alcohol consumption, physical activity, and dietary patterns have all been studied for their effects on breast density, but the findings are inconsistent enough that no major medical organization issues specific lifestyle recommendations aimed at reducing density. What is well established is that the same behaviors linked to lower breast cancer risk in general, such as limiting alcohol, maintaining a healthy weight, and staying physically active, are worth pursuing regardless of your density category. For someone with category B density, these habits contribute to overall breast health without needing to be framed as density-modification strategies.

What to Do With a Category B Result

If your mammogram report comes back with a density classification of B, the most useful thing you can do is understand what it is not. It is not a diagnosis. It is not a sign that something is wrong. It is a description of what your breast tissue looks like on an X-ray image, and it places you in a group where standard mammographic screening works relatively well. Continue getting screened at whatever interval your doctor recommends based on your age and overall risk profile. If you have questions about whether your other risk factors warrant additional imaging, bring those up at your next appointment.

One thing worth paying attention to over time is whether your category stays stable or shifts. If you consistently fall in category B across multiple mammograms, that consistency suggests the classification is reliable for you. If it bounces between B and C from year to year, the boundary question discussed earlier may be at play, and it is worth a conversation with your radiologist or primary care provider about how to interpret the fluctuation. Some women in that gray zone between B and C may benefit from a more individualized approach to screening rather than relying solely on which side of the line they happen to land on in any given year.